Aadi Bioscience, Inc. (AADI) Financials

$2.79

south_east
-$0.07 (-2.45%)
Day's range
$2.78
Day's range
$2.88
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning201720172018201820192019202020202021202120222022202320230%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%Profit Margin
Profit Margin
Revenue
Earnings

AADI Income statement / Annual

Last year (2023), Aadi Bioscience, Inc.'s total revenue was $24.35 M, an increase of 60.06% from the previous year. In 2023, Aadi Bioscience, Inc.'s net income was -$65.77 M. See Aadi Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $24.35 M $15.22 M $1.00 M $14.00 M $749,000.00 $20.16 M $0.00 $0.00 $0.00 $0.00
Cost of Revenue $2.81 M $1.34 M $276,000.00 $176,000.00 $76,501.00 $0.00 $51,268.00 $69,673.00 $57,977.00 $23,972.00
Gross Profit $21.55 M $13.88 M $724,000.00 $13.82 M $672,499.00 $20.16 M -$51,268.00 -$69,673.00 -$57,977.00 -$23,972.00
Gross Profit Ratio 0.88 0.91 0.72 0.99 0.9 1 0 0 0 0
Research and Development Expenses $48.93 M $32.66 M $19.67 M $15.01 M $12.82 M $17.85 M $12.15 M $11.37 M $11.63 M $0.00
General & Administrative Expenses $0.00 $0.00 $18.51 M $2.12 M $1.85 M $13.49 M $9.24 M $29,492.00 $23,006.00 $22,824.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $7.83 M -$46,686.00 -$51,268.00 $5.17 M $5.78 M $0.00
Selling, General & Administrative Expenses $44.55 M $40.18 M $18.51 M $2.12 M $9.68 M $13.44 M $9.19 M $5.20 M $5.80 M $22,824.00
Other Expenses $0.00 $5.06 M -$120,000.00 -$580,000.00 -$142,729.00 -$6,394.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $93.48 M $72.84 M $38.06 M $16.55 M $22.50 M $31.29 M $21.34 M $16.56 M $17.43 M $22,824.00
Cost And Expenses $96.29 M $74.17 M $38.06 M $16.55 M $22.58 M $31.34 M $21.39 M $16.63 M $17.49 M $22,824.00
Interest Income $6.40 M $2.40 M $13,000.00 $41,000.00 $1.03 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $231,000.00 $230,000.00 $665,000.00 $815,000.00 $0.00 $778,215.00 -$105,782.00 $9,942.00 $8,434.00 $5,877.00
Depreciation & Amortization $169,000.00 $159,000.00 $276,000.00 $176,000.00 $76,501.00 $46,686.00 $51,268.00 $69,673.00 $57,977.00 $0.00
EBITDA -$65.37 M -$60.12 M -$109.15 M -$2.49 M -$24.44 M -$10.35 M -$21.24 M -$16.43 M -$17.01 M -$22,824.00
EBITDA Ratio -2.68 -3.72 -35.46 -0.19 -30.05 -0.55 0 0 0 0
Operating Income Ratio -2.95 -3.87 -111.22 -0.18 -30.15 -0.55 0 0 0 0
Total Other Income/Expenses Net $6.17 M $2.17 M $1.13 M -$927,000.00 $1.17 M $784,605.00 -$12,066.00 -$349,926.00 $416,332.00 $17,145.00
Income Before Tax -$65.77 M -$60.51 M -$110.09 M -$3.48 M -$23.27 M -$10.40 M -$21.40 M -$16.98 M -$17.07 M -$28,701.00
Income Before Tax Ratio -2.7 -3.98 -110.09 -0.25 -31.07 -0.52 0 0 0 0
Income Tax Expense $0.00 -$3.50 M $2,000.00 $2,000.00 $1,300.00 $778,215.00 -$12,063.00 -$3.00 $3.00 $0.00
Net Income -$65.77 M -$57.01 M -$110.09 M -$3.48 M -$23.27 M -$10.40 M -$21.40 M -$16.98 M -$17.07 M -$28,701.00
Net Income Ratio -2.7 -3.75 -110.09 -0.25 -31.07 -0.52 0 0 0 0
EPS -2.44 -2.53 -12.34 -20.52 -8.6 -4.6 -14.81 -9.42 -9.47 -0.0159
EPS Diluted -2.44 -2.53 -12.34 -20.52 -8.6 -4.6 -14.81 -9.42 -9.47 -0.0159
Weighted Average Shares Out $26.92 M $22.51 M $8.92 M $169,490.00 $2.71 M $2.26 M $1.44 M $1.80 M $1.80 M $1.80 M
Weighted Average Shares Out Diluted $26.92 M $22.51 M $8.92 M $169,490.00 $2.71 M $2.26 M $1.44 M $1.80 M $1.80 M $1.80 M
Link